Longevity Health
(NASDAQ) CTCX
Longevity Health Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$1.91M
Net Income (TTM)
$6.91M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CTCX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Longevity Health
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
Rajiv Sarman Shukla
Website
www.carmellcosmetics.comHeadquarters
Pittsburgh, PA 15203, US
CTCX Financials
Key Financial Metrics (TTM)
Gross Margin
57%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
2%
Return on Capital
1%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.09M
Operating Income
$7.11M
EBITDA
$6.81M
Operating Cash Flow
$3.33M
Capital Expenditure
$14.22K
Free Cash Flow
$3.34M
Cash & ST Invst.
$706.74K
Total Debt
$309.94K
Longevity Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$472.98K
+2606.0%
Gross Profit
$267.82K
+1547.7%
Gross Margin
56.62%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
9
N/A
Net Income
$2.08M
-127.9%
EBITDA
$2.04M
-111.4%
Quarterly Fundamentals
Net Cash
$396.80K
+182.3%
Accounts Receivable
$36.50K
-88.1%
Inventory
$963.03K
+785.9%
Long Term Debt
$214.75K
-30.7%
Short Term Debt
$95.19K
-71.1%
Return on Assets
-2.92%
N/A
Return on Invested Capital
1.28%
N/A
Free Cash Flow
$320.59K
+58.5%
Operating Cash Flow
$306.37K
+60.3%